北京大学学报(医学版) ›› 2021, Vol. 53 ›› Issue (6): 1020-1025. doi: 10.19723/j.issn.1671-167X.2021.06.002

• 论著 • 上一篇    下一篇

类风湿关节炎患者外周血TWEAK基因启动子区甲基化状态及其表达

娄雪,廖莉,李兴珺,王楠,刘爽,崔若玫,徐健()   

  1. 昆明医科大学第一附属医院风湿免疫科,昆明 650032
  • 收稿日期:2021-08-16 出版日期:2021-12-18 发布日期:2021-12-13
  • 通讯作者: 徐健 E-mail:casxujian@163.com
  • 基金资助:
    国家自然科学基金(81760296);国家自然科学基金(81501406);国家自然科学基金(81460256);云南省医疗卫生单位内设研究机构科研项目(2017NS051);云南省医疗卫生单位内设研究机构科研项目(2018NS0133);云南省医疗卫生单位内设研究机构科研项目(2018NS0134);云南省高层次卫生计生技术后备人才(H-2017068);昆明医科大学“百名中青年学术和技术骨干”(60117190457);2018年云南省“万人计划”青年拔尖人才(YNWR-QNBJ-2018-152);云南省高层次卫生技术人才(领军人才)(L-2019004)(L-2019004);云南省“万人计划”名医(YNWR-MY-2018-040);云南省皮肤免疫性疾病临床医学中心(ZX2019-03-02);云南省临床皮肤与免疫疾病临床医学研究中心(2019ZF012)

Methylation status and expression of TWEAK gene promoter region in peripheral blood of patients with rheumatoid arthritis

LOU Xue,LIAO Li,LI Xing-jun,WANG Nan,LIU Shuang,CUI Ruo-mei,XU Jian()   

  1. Department of Rheumatology and Immunology, First Affiliated Hospital of Kunming Medical University, Kunming 650032, China
  • Received:2021-08-16 Online:2021-12-18 Published:2021-12-13
  • Contact: Jian XU E-mail:casxujian@163.com
  • Supported by:
    National Natural Science Foundation of China(81760296);National Natural Science Foundation of China(81501406);National Natural Science Foundation of China(81460256);Yunnan Provincial Health Science and Technology Plan(2017NS051);Yunnan Provincial Health Science and Technology Plan(2018NS0133);Yunnan Provincial Health Science and Technology Plan(2018NS0134);Yunnan Provincial Fund for High Level Reserve Talents in Health Science(H-2017068);Hundred-Talent Program of Kunming Medical University(60117190457);Youth Talent of Ten Thousand Scientists Program of Yunnan Province(YNWR-QNBJ-2018-152);Yunnan Province High-level Health Technical Talents (Leading Talents)(L-2019004);Yunnan Province Special Project for Famous Medical Talents of the “Ten Thousand Talents Program”(YNWR-MY-2018-040);Yunnan Province Clinical Center for Skin Immune Diseases(ZX2019-03-02);Yunnan Province Clinical Research Center for Skin Immune Diseases(2019ZF012)

摘要:

目的:通过检测外周血肿瘤坏死因子样凋亡弱诱导剂(tumor necrosis factor-like weak inducer of apoptosis,TWEAK)基因DNA甲基化水平、mRNA表达水平及血清蛋白浓度,探究TWEAK基因与类风湿关节炎(rheumatoid arthritis,RA)发病机制的关联。方法:采用MassARRAY法检测112例RA患者和86例匹配的健康志愿者外周血TWEAK基因DNA甲基化水平,采用实时荧光定量PCR法检测外周血TWEAK基因mRNA表达水平,采用酶联免疫吸附测定法检测血清TWEAK蛋白浓度。比较RA组和健康对照组TWEAK基因DNA甲基化水平、mRNA表达水平及血清蛋白浓度,并分析其与疾病活动度的关系。结果:RA组TWEAK基因总体甲基化水平和CpG_11、CpG_17.18.19.20、CpG_40.41.42位点甲基化水平高于健康对照组(P=0.002,P=0.01,P=0.006,P=0.002),高疾病活动度组CpG_55.56位点甲基化水平高于中低疾病活动度组(P=0.041)。RA组外周血TWEAK基因mRNA表达水平低于健康对照组(P=0.023),高疾病活动度组TWEAK基因mRNA表达水平低于中低疾病活动度组(P=0.035)。RA组血清TWEAK蛋白浓度与健康对照组差异无统计学意义(P=0.508), 但其与mRNA表达水平呈正相关(r=0.482,P<0.001)。结论:TWEAK基因与RA的发病和病情活动程度密切相关,其高甲基化状态可能为调控mRNA低表达的表观遗传学机制之一,可作为临床监测和评价RA病情的重要指标之一。

关键词: 肿瘤坏死因子样凋亡弱诱导剂, DNA甲基化, 信使RNA, 类风湿关节炎

Abstract:

Objective: To explore the relationship between tumor necrosis factor like weak inducer of apoptosis (TWEAK) gene and the pathogenesis of rheumatoid arthritis (RA) by detecting the DNA methylation level, mRNA expression level and serum protein concentration of TWEAK gene in peripheral blood. Methods: The MassARRAY method was used to detect the DNA methylation level of the TWEAK gene in the peripheral blood of 112 RA patients and 86 matched healthy volunteers. The real-time quantitative polymerase chain reaction method was used to detect the mRNA expression level of the TWEAK gene in the peripheral blood of the subjects. The enzyme-linked immunosorbent assay method was used to detect the serum TWEAK protein concentration of the subjects. The TWEAK gene DNA methylation level, mRNA expression level and serum protein concentration between the RA group and the healthy control group were compared, and the relationship between it and the degree of disease activity analyzed. Results: The overall DNA methylation level of TWEAK gene and the DNA methylation levels of CpG_11, CpG_17.18.19.20, CpG_40.41.42 site in the RA group were higher than those in the healthy control group (P=0.002, P=0.01, P=0.006, P=0.002, respectively). The DNA methylation level of CpG_55.56 site in the high disease activity group was higher than that in the medium and low disease activity group (P=0.041). The expression level of TWEAK gene mRNA in the peripheral blood of the RA group was lower than that of the healthy control group (P=0.023). The expression level of TWEAK gene mRNA in the high disease activity group was lower than that in the medium and low disease activity group (P=0.035). The serum TWEAK protein concentration of the RA group was not significantly different from that of the healthy control group (P=0.508), but it was positively correlated with the mRNA expression level (r=0.482, P<0.001). Conclusion: The TWEAK gene is closely related to the onset and progression of RA, and its hypermethylation state may be one of the epigenetic mechanisms regulating its low mRNA expression, and it can be used as one of the important indicators for clinical monitoring and evaluation of RA.

Key words: Tumor necrosis factor-like weak inducer of apoptosis, DNA methylation, mRNA, Rheumatoid arthritis

中图分类号: 

  • R593.22

图1

RA组和健康对照组各位点DNA甲基化水平比较"

表1

高疾病活动度组与中低疾病活动度组的甲基化水平比较($\overline{x}$±s)"

Items High disease
activity group (n=24)
Medium and low
disease activity group (n=16)
t value P value
Overall methylation level/% 0.078±0.008 0.077±0.009 -0.579 0.566
CpG_55.56/% 0.241±0.048 0.216±0.028 -2.112 0.041

图2

血清TWEAK蛋白浓度与mRNA表达水平的相关性"

[1] Firestein GS. Evolving concepts of rheumatoid arthritis[J]. Nature, 2003, 423(6937):356-361.
doi: 10.1038/nature01661
[2] Sánchez-Ramón S, López-Longo FJ, Carreño L. Interleukins network in rheumatoid arthritis pathophysiology: Beyond proinflammatory cytokines[J]. Reumatol Clin, 2011, 6(S3):S20-S24.
[3] Song X, Lin Q. Genomics, transcriptomics and proteomics to elucidate the pathogenesis of rheumatoid arthritis[J]. Rheumatol Int, 2017, 37(8):1257-1265.
doi: 10.1007/s00296-017-3732-3
[4] Karami J, Aslani S, Jamshidi A, et al. Genetic implications in the pathogenesis of rheumatoid arthritis: An updated review[J]. Gene, 2019, 702:8-16.
doi: S0378-1119(19)30290-2 pmid: 30904715
[5] Park J, Kwok S, Lim M, et al. TWEAK promotes osteoclastogenesis in rheumatoid arthritis[J]. Am J Pathol, 2013, 183(3):857-867.
doi: 10.1016/j.ajpath.2013.05.027
[6] Chicheportiche Y, Chicheportiche R, Sizing I, et al. Proinflammatory activity of TWEAK on human dermal fibroblasts and synoviocytes: Blocking and enhancing effects of anti-TWEAK monoclonal antibodies[J]. Arthritis Res, 2002, 4(2):126-133.
pmid: 11879548
[7] Karami J, Aslani S, Tahmasebi MN, et al. Epigenetics in rheumatoid arthritis; fibroblast-like synoviocytes as an emerging paradigm in the pathogenesis of the disease[J]. Immunol Cell Biol, 2020, 98(3):171-186.
doi: 10.1111/imcb.12311 pmid: 31856314
[8] Singer BD. A practical guide to the measurement and analysis of DNA methylation[J]. Am J Respir Cell Mol Biol, 2019, 61(4):417-428.
doi: 10.1165/rcmb.2019-0150TR
[9] Hua XM, Wang J, Qian DM, et al. DNA methylation level of promoter region of activating transcription factor 5 in glioma[J]. J Zhejiang Univ Sci B, 2015, 16(9):757-762.
doi: 10.1631/jzus.B1500067
[10] Fuso A, Raia T, Orticello M, et al. The complex interplay between DNA methylation and miRNAs in gene expression regulation[J]. Biochimie, 2020, 173:12-16.
doi: 10.1016/j.biochi.2020.02.006
[11] 中华医学会风湿病学分会. 类风湿关节炎诊断及治疗指南[J]. 中华风湿病学杂志, 2010(4):265-270.
[12] Schwartz N, Su L, Burkly LC, et al. Urinary TWEAK as a biomarker of lupus nephritis: A multicenter cohort study[J]. Arthritis Res Ther, 2009, 11(5):R143.
doi: 10.1186/ar2816
[13] Xu W, Zhao Y, Liu Y. Role of the TWEAK/Fn14 pathway in autoimmune diseases[J]. Immunol Res, 2016, 64(1):44-50.
doi: 10.1007/s12026-015-8761-y
[14] Kamijo S, Nakajima A, Kamata K, et al. Involvement of TWEAK/Fn14 interaction in the synovial inflammation of RA[J]. Rheumatology (Oxford), 2008, 47(4):442-450.
doi: 10.1093/rheumatology/ken006 pmid: 18310134
[15] Bertin D, Stephan D, Khrestchatisky M, et al. Is TWEAK a biomarker for autoimmune/chronic inflammatory diseases[J]. Front Immunol, 2013(4):489.
[16] van Kuijk AW, Wijbrandts CA, Vinkenoog M, et al. TWEAK and its receptor Fn14 in the synovium of patients with rheumatoid arthritis compared to psoriatic arthritis and its response to tumour necrosis factor blockade[J]. Ann Rheum Dis, 2010, 69(1):301-304.
doi: 10.1136/ard.2008.090548 pmid: 19147618
[17] Park MC, Chung SJ, Jung SJ, et al. Relationship of serum TWEAK level to cytokine level, disease activity, and response to anti-TNF treatment in patients with rheumatoid arthritis[J]. Scand J Rheumatol, 2008, 37(3):173-178.
doi: 10.1080/03009740801898608 pmid: 18465450
[18] Dharmapatni A, Smith MD, Crotti TN, et al. TWEAK and Fn14 expression in the pathogenesis of joint inflammation and bone erosion in rheumatoid arthritis[J]. Arthritis Res Ther, 2011, 13(2):R51.
doi: 10.1186/ar3294
[19] Maecker H, Varfolomeev E, Kischkel F, et al. TWEAK attenuates the transition from innate to adaptive immunity[J]. Cell, 2005, 123(5):931-944.
doi: 10.1016/j.cell.2005.09.022
[20] Guo SC, Zhu Q, Jiang T, et al. Genome-wide DNA methylation patterns in CD4+ T cells from Chinese Han patients with rheumatoid arthritis[J]. Mod Rheumatol, 2017, 27(3):441-447.
doi: 10.1080/14397595.2016.1218595
[21] Zhu H, Wu LF, Mo XB, et al. Rheumatoid arthritis-associated DNA methylation sites in peripheral blood mononuclear cells[J]. Ann Rheum Dis, 2019, 78(1):36-42.
doi: 10.1136/annrheumdis-2018-213970
[1] 高超,陈立红,王莉,姚鸿,黄晓玮,贾语博,刘田. 类风湿关节炎合并纤维肌痛简易分类标准的临床验证[J]. 北京大学学报(医学版), 2022, 54(2): 278-282.
[2] 张璐,胡小红,陈澄,蔡月明,王庆文,赵金霞. 类风湿关节炎初治患者颈椎失稳情况及临床特征[J]. 北京大学学报(医学版), 2021, 53(6): 1049-1054.
[3] 罗靓,霍文岗,张钦,李春. 类风湿关节炎合并角膜溃疡的临床特点和相关因素分析[J]. 北京大学学报(医学版), 2021, 53(6): 1032-1036.
[4] 钟华,徐丽玲,白明欣,苏茵. 类风湿关节炎患者趋化因子CXCL9和CXCL10在骨侵蚀中的作用[J]. 北京大学学报(医学版), 2021, 53(6): 1026-1031.
[5] 曹迪,王燕,王柳青,孙晓麟,黄妃,孟洋,任丽丽,张学武. 血浆Dickkopf-1在类风湿关节炎患者中的表达及其与外周血T细胞亚群的相关性[J]. 北京大学学报(医学版), 2021, 53(2): 255-260.
[6] 赵凯,常志芳,王志华,庞春艳,王永福. 基因沉默肽基精氨酸脱亚胺酶4的表达对胶原诱导关节炎小鼠肺间质病变的影响[J]. 北京大学学报(医学版), 2021, 53(2): 235-239.
[7] 钟剑球,曾沛英,王庆文. 类风湿关节炎合并淋巴水肿2例及文献回顾[J]. 北京大学学报(医学版), 2020, 52(6): 1157-1161.
[8] 张警丰,叶修玲,段萌,周小利,姚中强,赵金霞. 抗核抗体阳性类风湿关节炎的临床和实验室检查特点[J]. 北京大学学报(医学版), 2020, 52(6): 1023-1028.
[9] 唐果,龙丽,韩雅欣,彭清,刘佳君,尚华. 类风湿关节炎合并结核感染的临床特点及相关因素[J]. 北京大学学报(医学版), 2020, 52(6): 1029-1033.
[10] 张璐,胡小红,王庆文,蔡月明,赵金霞,刘湘源. 类风湿关节炎合并颈椎失稳的人群分布及临床特征[J]. 北京大学学报(医学版), 2020, 52(6): 1034-1039.
[11] 陈家丽,金月波,王一帆,张晓盈,李静,姚海红,何菁,李春. 老年发病类风湿关节炎的临床特征及其心血管疾病危险因素分析:一项大样本横断面临床研究[J]. 北京大学学报(医学版), 2020, 52(6): 1040-1047.
[12] 彭嘉婧,刘田. 类风湿关节炎合并色素沉着绒毛结节性滑膜炎1例及文献回顾[J]. 北京大学学报(医学版), 2020, 52(6): 1135-1139.
[13] 罗采南,李正芳,武丽君,陈海娟,杨春梅,徐文晖,刘小玲,唐薇,乔平,热娜·白合提亚. 类风湿关节炎不同分类标准的多中心临床比较[J]. 北京大学学报(医学版), 2020, 52(5): 897-901.
[14] 王兆年,高文静,王碧琦,曹卫华,吕筠,余灿清,逄增昌,丛黎明,汪华,吴先萍,刘彧,李立明. 成年双生子空腹血糖、糖化血红蛋白与全基因组DNA甲基化的相关性研究[J]. 北京大学学报(医学版), 2020, 52(3): 425-431.
[15] 竺红,赵丽娟,周艳,陈瑶. 抗氨基甲酰化蛋白抗体在类风湿关节炎合并肺间质病变早期诊断中的价值[J]. 北京大学学报(医学版), 2019, 51(6): 1003-1007.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 张三. 中文标题测试[J]. 北京大学学报(医学版), 2010, 42(1): 1 -10 .
[2] 赵磊, 王天龙 . 右心室舒张末期容量监测用于肝移植术中容量管理的临床研究[J]. 北京大学学报(医学版), 2009, 41(2): 188 -191 .
[3] 万有, , 韩济生, John E. Pintar. 孤啡肽基因敲除小鼠电针镇痛作用增强[J]. 北京大学学报(医学版), 2009, 41(3): 376 -379 .
[4] 张燕, 韩志慧, 钟延丰, 王盛兰, 李玲玲, 郑丹枫. 骨骼肌活组织检查病理诊断技术的改进及应用[J]. 北京大学学报(医学版), 2009, 41(4): 459 -462 .
[5] 张安阳, 范田园. 运用响应曲面法优化核黄素磷酸钠海藻酸钙胃漂浮微球[J]. 北京大学学报(医学版), 2009, 41(6): 682 -686 .
[6] 赵奇, 薛世华, 刘志勇, 吴凌云. 同向施压测定自酸蚀与全酸蚀粘接系统粘接强度[J]. 北京大学学报(医学版), 2010, 42(1): 82 -84 .
[7] 林红, 王玉凤, 吴野平. 学校生活技能教育对小学三年级学生行为问题影响的对照研究[J]. 北京大学学报(医学版), 2007, 39(3): 319 -322 .
[8] 丰雷, 程嘉, 王玉凤. 注意缺陷多动障碍儿童的运动协调功能[J]. 北京大学学报(医学版), 2007, 39(3): 333 -336 .
[9] 李岳玲, 钱秋瑾, 王玉凤. 儿童注意缺陷多动障碍成人期预后及其预测因素[J]. 北京大学学报(医学版), 2007, 39(3): 337 -340 .
[10] . 书讯[J]. 北京大学学报(医学版), 2007, 39(3): 225 -328 .